Detalhe da pesquisa
1.
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).
Cancer Cell;
1(5): 421-32, 2002 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12124172
2.
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.
Cancer Cell;
3(5): 459-69, 2003 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12781364
3.
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model.
Oncogene;
24(53): 7882-92, 2005 Nov 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16116483
4.
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Proc Natl Acad Sci U S A;
99(12): 8283-8, 2002 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12060771